Abstract
ExoS and ExoT are bi-functional type-III cytotoxins of Pseudomonas aeruginosa that share 76% primary amino acid homology and contain N-terminal RhoGAP domains and C-terminal ADP-ribosylation domains. The Rho GAP activities of ExoS and ExoT appear to be biochemically and biologically identical, targeting Rho, Rac, and Cdc42. Expression of the RhoGAP domain in mammalian cells results in the disruption of the actin cytoskeleton and interference of phagocytosis. Expression of the ADP-ribosyltransferase domain of ExoS elicits a cytotoxic phenotype in cultured cells, while expression of ExoT appears to interfere with host cell phagocytic activity. Recent studies showed that ExoS and ExoT ADP-ribosylate different substrates. While ExoS has poly-substrate specificity and can ADP-ribosylate numerous host proteins, ExoT ADP-ribosylates a more restricted subset of host proteins including the Crk proteins. Protein modeling predicts that electrostatic interactions contribute to the substrate specificity of the ADP-ribosyltransferase domains of ExoS and ExoT.
Access provided by Autonomous University of Puebla. Download to read the full chapter text
Chapter PDF
Similar content being viewed by others
Keywords
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.
Abbreviations
- GAP:
-
GTPase activating protein
- ADP-r:
-
Adenosine diphosphate ribose
- MLD:
-
Membrane localization domain
- FAS:
-
Factor activating exoenzyme S
- Crk:
-
CT-10 regulator of kinase
- SBTI:
-
Soybean trypsin inhibitor
- GEF:
-
Guanine nucleotide exchange factor
References
Black DS, Marie-Cardine A, Schraven B, Bliska JB (2000) The Yersinia tyrosine phosphatase YopH targets a novel adhesion-regulated signalling complex in macrophages” Cell Microbiol 2(5):401–414
Blocker A, Jouihri N, Larquet E, Gounon P, Ebel F, Parsot C, Sansonetti P, Allaoui A (2001) Structure and composition of the Shigella flexneri “needle complex,” a part of its type III secreton” Mol Microbiol 39(3):652–663
Burton EA, Plattner R, Pendergast AM (2003) Abl tyrosine kinases are required for infection by Shigella flexneri” EMBO J 22(20):5471–5479
Coburn J (1992) Pseudomonas aeruginosa exoenzyme S. Curr Top Microbiol Immunol 175:133–143
Coburn J and Gill DM (1991) ADP-ribosylation of p21ras and related proteins by Pseudomonas aeruginosa exoenzyme S. Infect Immun 59(11):4259–4262
Coburn J, Dillon ST, Iglewski BH, Gill DM (1989) Exoenzyme S of Pseudomonas aeruginosa ADP-ribosylates the intermediate filament protein vimentin. Infect Immun 57(3):996–998
Coburn J, Wyatt RT, Iglewski BH, Gill DM (1989) Several GTP-binding proteins, including p21c-H-ras, are preferred substrates of Pseudomonas aeruginosa exoenzyme S. J Biol Chem 264(15):9004–9008
Coburn J, Kane AV, Feig L, Gill DM (1991) Pseudomonas aeruginosa exoenzyme S requires a eukaryotic protein for ADP-ribosyltransferase activity. J Biol Chem 266(10):6438–6446
Cowell BA, Chen DY, Frank DW, Vallis AJ, Fleiszig SM (2000) ExoT of cytotoxic Pseudomonas aeruginosa prevents uptake by corneal epithelial cells” Infect Immun 68(1):403–406
Finck-Barbancon V, Goranson J, Zhu L, Sawa T, Wiener-Kronish JP, Fleiszig SM, Wu C, Mende-Mueller L, Frank DW (1997) ExoU expression by Pseudomonas aeruginosa correlates with acute cytotoxicity and epithelial injury. Mol Microbiol 25(3):547–557
Fleiszig SM, Wiener-Kronish JP, Miyazaki H, Vallas V, Mostov KE, Kanada D, Sawa T, Yen TS, Frank DW (1997) Pseudomonas aeruginosa-mediated cytotoxicity and invasion correlate with distinct genotypes at the loci encoding exoenzyme S. Infect Immun 65(2):579–586
Frank DW (1997) The exoenzyme S regulon of Pseudomonas aeruginosa. Mol Microbiol 26(4):621–629
Frithz-Lindsten E, Du Y, Rosqvist R, Forsberg A (1997) Intracellular targeting of exoenzyme S of Pseudomonas aeruginosa via type III-dependent translocation induces phagocytosis resistance, cytotoxicity and disruption of actin microfilaments. Mol Microbiol 25(6):1125–1139
Fu H, Coburn J, Collier RJ (1993) The eukaryotic host factor that activates exoenzyme S of Pseudomonas aeruginosa is a member of the 14-3-3 protein family. Proc Natl Acad Sci U S A 90(6):2320–2324
Ganesan AK, Frank DW, Misra RP, Schmidt G, Barbieri JT (1998) Pseudomonas aeruginosa exoenzyme S ADP-ribosylates Ras at multiple sites. J Biol Chem 273(13):7332–7337
Ganesan AK, Mende-Mueller L, Selzer J, Barbieri JT (1999) Pseudomonas aeruginosa exoenzyme S, a double ADP-ribosyltransferase, resembles vertebrate mono-ADP-ribosyltransferases. J Biol Chem 274(14):9503–9508
Garrity-Ryan L, Kazmierczak B, Kowal R, Comolli J, Hauser A, Engel JN (2000) The arginine finger domain of ExoT contributes to actin cytoskeleton disruption and inhibition of internalization of Pseudomonas aeruginosa by epithelial cells and macrophages. Infect Immun 68(12):7100–7113
Geiser TK, Kazmierczak BI, Garrity-Ryan LK, Matthay MA, Engel JN (2001) Pseudomonas aeruginosa ExoT inhibits in vitro lung epithelial wound repair. Cell Microbiol 3(4):223–236
Goehring UM, Schmidt G, Pederson KJ, Aktories K, Barbieri JT (1999) The N-terminal domain of Pseudomonas aeruginosa exoenzyme S is a GTPase-activating protein for Rho GTPases. J Biol Chem 274(51):36369–36372
Han S, Craig JA, Putnam CD, Carozzi NB, Tainer JA (1999) Evolution and mechanism from structures of an ADP-ribosylating toxin and NAD complex. Nat Struct Biol 6(10):932–936
Han S, Arvai AS, Clancy SB, Tainer JA (2001) Crystal structure and novel recognition motif of rho ADP-ribosylating C3 exoenzyme from Clostridium botulinum: structural insights for recognition specificity and catalysis. J Mol Biol 305(1):95–107
Henriksson ML, Troller U, Hallberg B (2000) 14-3-3 proteins are required for the inhibition of Ras by exoenzyme S. Biochem J 349 Pt 3:697–701
Iglewski BH, Sadoff J, Bjorn MJ, Maxwell ES (1978) Pseudomonas aeruginosa exoenzyme S: an adenosine diphosphate ribosyltransferase distinct from toxin A. Proc Natl Acad Sci U S A 75(7):3211–3215
Jia J, Alaoui-El-Azher M, Chow M, Chambers TC, Baker H, Jin S (2003) c-Jun NH2-terminal kinase-mediated signaling is essential for Pseudomonas aeruginosa ExoS-induced apoptosis. Infect Immun 71(6):3361–3370
Kaufman MR, Jia J, Zeng L, Ha U, Chow M, Jin S (2000) Pseudomonas aeruginosa mediated apoptosis requires the ADP-ribosylating activity of exoS. Microbiology 146 (Pt 10):2531–2541
Kazmierczak BI and Engel JN (2002) Pseudomonas aeruginosa ExoT acts in vivo as a GTPase-activating protein for RhoA, Rac1, and Cdc42. Infect Immun 70(4):2198–2205
Knight DA, Finck-Barbancon V, Kulich SM, Barbieri JT (1995) Functional domains of Pseudomonas aeruginosa exoenzyme S. Infect Immun 63(8):3182–3186
Krall R, Schmidt G, Aktories K, Barbieri JT (2000) Pseudomonas aeruginosa ExoT is a Rho GTPase-activating protein. Infect Immun 68(10):6066–6068
Krall R, Sun J, Pederson KJ, Barbieri JT (2002) In vivo rho GTPase-activating protein activity of Pseudomonas aeruginosa cytotoxin ExoS. Infect Immun 70(1):360–367
Krall R, Zhang Y, Barbieri JT (2004) Intracellular membrane localization of pseudomonas ExoS and Yersinia YopE in mammalian cells. J Biol Chem 279(4):2747–2753
Kulich SM, Frank DW, Barbieri JT (1993) Purification and characterization of exoenzyme S from Pseudomonas aeruginosa 388. Infect Immun 61(1):307–313
Kulich SM, Yahr TL, Mende-Mueller LM, Barbieri JT, Frank DW (1994) Cloning the structural gene for the 49-kDa form of exoenzyme S (exoS) from Pseudomonas aeruginosa strain 388. J Biol Chem 269(14):10431–10437
Lanotte P, Watt S, Mereghetti L, Dartiguelongue N, Rastegar-Lari A, Goudeau A, Quentin R (2004) Genetic features of Pseudomonas aeruginosa isolates from cystic fibrosis patients compared with those of isolates from other origins. J Med Microbiol 53(1):73–81
Liu S, Kulich SM, Barbieri JT (1996) Identification of glutamic acid 381 as a candidate active site residue of Pseudomonas aeruginosa exoenzyme S. Biochemistry 35(8):2754–2758
Liu S, Yahr TL, Frank DW, Barbieri JT (1997) Biochemical relationships between the 53-kilodalton (Exo53) and 49-kilodalton (ExoS) forms of exoenzyme S of Pseudomonas aeruginosa. J Bacteriol 179(5):1609–1613
Lomholt JA, Poulsen K, Kilian M (2001) Epidemic population structure of Pseudomonas aeruginosa: evidence for a clone that is pathogenic to the eye and that has a distinct combination of virulence factors. Infect Immun 69(10):6284–6295
Marchalonis JJ, Schluter SF, Bernstein RM, Hohman VS (1998) Antibodies of sharks: revolution and evolution. Immunol Rev 166:103–122
Neyfakh AA (2002) Mystery of multidrug transporters: the answer can be simple. Mol Microbiol 44(5):1123–1130
Nicas, TI and Iglewski BH (1984) Isolation and characterization of transposon-induced mutants of Pseudomonas aeruginosa deficient in production of exoenzyme S. Infect Immun 45(2):470–474
Pederson KJ, Vallis AJ, Aktories K, Frank DW, Barbieri JT (1999) The amino-terminal domain of Pseudomonas aeruginosa ExoS disrupts actin filaments via small-molecular-weight GTP-binding proteins. Mol Microbiol 32(2):393–401
Pederson KJ, Pal S, Vallis AJ, Frank DW, Barbieri JT (2000) Intracellular localization and processing of Pseudomonas aeruginosa ExoS in eukaryotic cells. Mol Microbiol 37(2):287–299
Pederson KJ, Krall R, Riese MJ, Barbieri JT (2002) Intracellular localization modulates targeting of ExoS, a type III cytotoxin, to eukaryotic signalling proteins. Mol Microbiol 46(5):1381–1390
Persson C, Carballeira N, Wolf-Watz H, Fallman M (1997) The PTPase YopH inhibits uptake of Yersinia, tyrosine phosphorylation of p130Cas and FAK, and the associated accumulation of these proteins in peripheral focal adhesions. EMBO J 16(9):2307–2318
Petosa C, Masters SC, Bankston LA, Pohl J, Wang B, Fu H, Liddington RC (1998) 14-3-3zeta binds a phosphorylated Raf peptide and an unphosphorylated peptide via its conserved amphipathic groove. J Biol Chem 273(26):16305–16310
Radke J, Pederson KJ, Barbieri JT (1999) Pseudomonas aeruginosa exoenzyme S is a biglutamic acid ADP-ribosyltransferase. Infect Immun 67(3):1508–1510
Riese MJ and Barbieri JT (2002) Membrane localization contributes to the in vivo ADP-ribosylation of Ras by Pseudomonas aeruginosa ExoS. Infect Immun 70(4):2230–2232
Riese MJ, Wittinghofer A, Barbieri JT (2001) ADP ribosylation of Arg41 of Rap by ExoS inhibits the ability of Rap to interact with its guanine nucleotide exchange factor, C3G. Biochemistry 40(11):3289–3294
Riese MJ, Goehring UM, Ehrmantraut ME, Moss J, Barbieri JT, Aktories K, Schmidt G (2002) Auto-ADP-ribosylation of Pseudomonas aeruginosa ExoS. J Biol Chem 277(14):12082–12088
Sato H, Frank DW, Hillard CJ, Feix JB, Pankhaniya RR, Moriyama K, Finck-Barbancon V, Buchaklian A, Lei M, et al. (2003) The mechanism of action of the Pseudomonas aeruginosa-encoded type III cytotoxin, ExoU. EMBO J 22(12):2959–2969
Sun J and Barbieri JT (2003) Pseudomonas aeruginosa ExoT ADP-ribosylates CT10 regulator of kinase (Crk) proteins. J Biol Chem 278(35):32794–32800
Sun J and Barbieri JT (2004) How bacterial ADP-ribosylating toxins recognize substrates. Nat Struct Mol Biol (in press)
Sundin C, Henriksson ML, Hallberg B, Forsberg A, Frithz-Lindsten E (2001) Exoenzyme T of Pseudomonas aeruginosa elicits cytotoxicity without interfering with Ras signal transduction. Cell Microbiol 3(4):237–246
Vallis AJ, Finck-Barbancon V, Yahr TL, Frank DW (1999) Biological effects of Pseudomonas aeruginosa type III-secreted proteins on CHO cells. Infect Immun 67(4):2040–2044
Van Delden C and Iglewski BH (1998) Cell-to-cell signaling and Pseudomonas aeruginosa infections. Emerg Infect Dis 4(4):551–560
Wurtele M, Renault L, Barbieri JT, Wittinghofer A, Wolf E (2001) Structure of the ExoS GTPase activating domain. FEBS Lett 491(1–2):26–29
Wurtele M, Wolf E, Pederson KJ, Buchwald G, Ahmadian MR, Barbieri JT, Wittinghofer A (2001) How the Pseudomonas aeruginosa ExoS toxin downregulates Rac. Nat Struct Biol 8(1):23–26
Yahr TL, Barbieri JT, Frank DW (1996) Genetic relationship between the 53-and 49-kilodalton forms of exoenzyme S from Pseudomonas aeruginosa. J Bacteriol 178(5):1412–1419
Yahr TL, Vallis AJ, Hancock MK, Barbieri JT, Frank DW (1998) ExoY, an adenylate cyclase secreted by the Pseudomonas aeruginosa type III system. Proc Natl Acad Sci U S A 95(23):13899–13904
Zhang L, Wang H, Liu D, Liddington R, Fu H (1997) Raf-1 kinase and exoenzyme S interact with 14-3-3zeta through a common site involving lysine 49. J Biol Chem 272(21):13717–13724
Zhang L, Wang H, Masters SC, Wang B, Barbieri JT, Fu H (1999) Residues of 14-3-3 zeta required for activation of exoenzyme S of Pseudomonas aeruginosa. Biochemistry 38(37):12159–12164
Zheleznova EE, Markham PN, Neyfakh AA, Brennan RG (1999) Structural basis of multidrug recognition by BmrR, a transcription activator of a multidrug transporter. Cell 96(3):353–362
Zheleznova EE, Markham P, Edgar R, Bibi E, Neyfakh AA, Brennan RG (2000) A structure-based mechanism for drug binding by multidrug transporters. Trends Biochem Sci 25(2):39–43
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
Copyright information
© 2004 Springer-Verlag
About this chapter
Cite this chapter
Barbieri, J.T., Sun, J. (2004). Pseudomonas aeruginosa ExoS and ExoT. In: Reviews of Physiology, Biochemistry and Pharmacology. Reviews of Physiology, Biochemistry and Pharmacology, vol 152. Springer, Berlin, Heidelberg. https://doi.org/10.1007/s10254-004-0031-7
Download citation
DOI: https://doi.org/10.1007/s10254-004-0031-7
Published:
Publisher Name: Springer, Berlin, Heidelberg
Print ISBN: 978-3-540-23131-8
Online ISBN: 978-3-540-27115-4
eBook Packages: Biomedical and Life SciencesBiomedical and Life Sciences (R0)